FDA report urges stronger warnings for acetaminophen

05/27/2009 | Bloomberg

An FDA working group released a report urging reduced doses of drugs containing acetaminophen and warnings about liver injury linked to such drugs. The report, which also advises against using acetaminophen in nonprescription combination products such as Tylenol Cold, will be discussed by FDA advisory panels June 29 and 30.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA